Clinical Trial Update: Safety of Soluble Beta-Glucan (SBG) in Treatment of Patients With Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety of Soluble Beta-Glucan in patients with Non-Hodgkin lymphoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Soluble Beta-Glucan (SBG) (soluble beta-glucan)

Snippet

Sponsor: Biotec Pharmacon ASA | Conditions: Non-Hodgkin's Lymphoma | Phase 1 | Status: COMPLETED